Clinical trial knowledge among cancer survivors in the United States: the role of health information technology.

Autor: Akhiwu TO; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA. Ted.o.akhiwu@medstar.net.; MedStar Health Internal Medicine Residency Program, 201 E University Parkway, Baltimore, MD, 21218, USA. Ted.o.akhiwu@medstar.net., Adewunmi C; Division of Geriatrics and Gerontology, Emory University School of Medicine, Atlanta, GA, USA., Bilalaga M; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA., Atarere JO; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA., Gaddipati G; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA., Chido-Amajuoyi OG; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA., Eziuche DK; Department of Public Health, National Open University, Abuja, Nigeria., Onyeaka H; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA., Amonoo HL; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.
Jazyk: angličtina
Zdroj: Cancer causes & control : CCC [Cancer Causes Control] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
DOI: 10.1007/s10552-024-01928-7
Abstrakt: Purpose: Clinical trials are essential to the advancement of cancer care. However, clinical trial knowledge and participation remain critically low among adult patients with cancer. Health information technology (HIT) could play an important role in improving clinical trial knowledge and engagement among cancer survivors.
Methods: We used data from 3,794 adults who completed the 2020 Health Information National Trends Survey, 626 (16.2%) of whom were cancer survivors. We examined the prevalence of HIT use in the study population and by cancer history using chi-squared tests. We used multivariable logistic regression models to examine the impact of HIT use on clinical trial knowledge for cancer survivors and respondents with no cancer history, respectively.
Results: Approximately 63.8% of cancer survivors reported having some knowledge of clinical trials. Almost half of the cancer survivors used HIT to communicate with doctors (47.1%) and make health appointments (49.4%), 68.0% used HIT to look up health information online and 42.2% used it to check test results. In the adjusted models, the use of HIT in communicating with doctors [OR 2.79; 95% CI (1.41, 5.54)], looking up health information online [OR 2.84; 95% CI (1.04, 7.77)], and checking test results [OR 2.47; 95% CI (1.12, 5.43)] was associated with having some knowledge of clinical trials.
Conclusion: HIT use for engaging with the healthcare team and health information gathering is associated with higher clinical trial knowledge in cancer survivors. Given the rapid increase in mobile technology access globally and the increased use of HIT, digital technology can be leveraged to improve clinical trial knowledge and engagement among cancer survivors.
(© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Databáze: MEDLINE
Externí odkaz: